Modular Chamber Assembled with Cell-Replicated Surface for Capture of Cancer Cells

Modular Chamber Assembled with Cell-Replicated Surface for Capture of Cancer Cells
复制标题

组装有细胞复制表面的模块化室用于捕获癌细胞

DOI:
10.1021/acsbiomaterials.8b01605
复制
发表时间:
2019
影响因子:
--
通讯作者:
Jia Lingyun
Jia Lingyun
中科院分区:
工程技术2区
文献类型:
--
作者:
Sun He;Hang Lulu;Yang Liwei;Yang Yan;Jiang Wenning;Xu Ting;Jia Lingyun

文献摘要

相似文献

循环肿瘤细胞(CTC)的捕获主要是使用磁性纳米颗粒和复杂的微流体用少量血液进行的。在这项研究中,我们提出了一个CTC捕获装置的基础上,模块化设计,并呼吁该装置作为CTC室。与其他CTC捕获装置不同,CTC室的容量可以通过改变CTC捕获模块的数量来改变,以容纳不同体积的血液样品。CTC捕获模块的核心组件是具有细胞复制拓扑结构和抗EpCAM抗体涂层的聚二甲基硅氧烷(PDMS)膜。这两种协同作用可以提高癌细胞的捕获率。此外,CTC腔室与一个或三个CTC捕获模块组装,用于从代表晚期(3 mL血液,10个癌细胞mL-1)或中早期(9 mL血液,1个癌细胞mL-1)癌症的掺入血液样品中捕获癌细胞。结果表明,在1 h内可获得较高的捕获率(EpCAM阳性,约80%; EpCAM阴性,约65%)和纯度(EpCAM阳性,约90%; EpCAM阴性,约80%)。因此,这种经济和简便的CTC室可以为设计适用于诊断不同阶段癌症的下一代CTC检测设备提供机会。
The capture of circulating tumor cells (CTCs) is mainly carried out with a small volume of blood using magnetic nanoparticles and complex microfluidics. In this study, we propose a CTC-capture apparatus based on a modular design and called this apparatus as the CTC chamber. Distinct from other CTC-capture apparatuses, the capacity of the CTC chamber could be altered by varying the number of CTC-capture modules to accommodate the different volumes of blood sample. The core component of the CTC-capture module was a polydimethylsiloxane (PDMS) film with cell-replicated topological structure and anti-EpCAM antibody coating. Both synergistic roles can enhance the capture yield of cancer cells. Furthermore, the CTC chamber was assembled with one or three CTC-capture modules for the capture of cancer cells from spiked blood samples representing late-stage (3 mL of blood, 10 cancer cells mL–1) or middle-early stage (9 mL of blood, 1 cancer cell mL–1) cancer. The results showed that high capture yield (EpCAM-positive, ∼80%; EpCAM-negative, ∼65%) and purity (EpCAM-positive, ∼90%; EpCAM-negative, ∼80%) could be obtained within 1 h. This economic and facile CTC chamber could therefore open up opportunities for designing the next-generation CTC detection devices suitable for the diagnosis of different stages of cancer.